Export

Infant Bacterial Therapeutics AB

Financial information

The information source is the annual report of the company with business id 556873-8586

* Closing information (×1000) SEK

Fiscal year 202412 202312
Number of months: 12 12
Turnover: 0 0
Financial expenses: 0 0 Revenue Down
Earnings before taxes: -136,905 Revenue Down -123,066 Revenue Down
Total assets: 239,566 Revenue Down 351,334 Revenue Up
Current assets: 230,610 Revenue Down 341,563 Revenue Up
Current liabilities: 69,303 Revenue Up 46,180 Revenue Up
Equity capital: 170,263 Revenue Down 305,154 Revenue Down
Share capital: 3,672 3,672 Revenue Up
Number of employees: 10 Revenue Up 8 Revenue Up

Financial ratios

Solvency: 71.1% Revenue Down 86.9% Revenue Down
Turnover per employee: 0 0
Profitability: -Infinity% -Infinity%
Return on equity (ROE): -80.4% Revenue Down -40.3% Revenue Down
Current ratio: 332.8% Revenue Down 739.6% Revenue Down
Return on assets (ROA): -57.1% Revenue Down -35.0% Revenue Down

Companies with similar products and services, and with detailed information

Fiscal year 202412
Number of months: 12
Turnover: 0
Financial expenses: 0
Earnings before taxes: -136,905
Total assets: 239,566
Current assets: 230,610
Current liabilities: 69,303
Equity capital: 170,263
Share capital: 3,672
Number of employees: 10

Financial ratios

Solvency: 71.1%
Turnover per employee: 0
Profitability: -Infinity%
Return on equity (ROE): -80.4%
Current ratio: 332.8%
Return on assets (ROA): -57.1%